High-Dose Chemotherapy With Hematopoietic Stem Cell Transplant in Patients With High-Risk Breast Cancer and 4 or More Involved Axillary Lymph Nodes 20-Year Follow-up of a Phase 3 Randomized Clinical Trial

Autor: Caroline M. Seynaeve, Elsken van der Wall, Elisabeth G.E. de Vries, Wim M. Smit, Jacobus J M van der Hoeven, Vivianne C. G. Tjan-Heijnen, Judith R. Kroep, Harm van Tinteren, Flora E. van Leeuwen, Judy N. Jacobse, Jourik A. Gietema, Carolien P. Schröder, Lars C Steggink, Gabe S. Sonke, Maartje J. Hooning, Tessa G Steenbruggen, Sabine C. Linn, Michael Schaapveld, Inge R Konings, Agnes Jager, Adriaan Bins

Publikováno v: Jama Oncology, 6, 4, pp. 528-534
JAMA Oncology, 6(4), 528-534. American Medical Association
Steenbruggen, T G, Steggink, L C, Seynaeve, C M, Van Der Hoeven, J J M, Hooning, M J, Jager, A, Konings, I R, Kroep, J R, Smit, W M, Tjan-Heijnen, V C G, Van Der Wall, E, Bins, A D, Linn, S C, Schaapveld, M, Jacobse, J N, Van Leeuwen, F E, Schröder, C P, Van Tinteren, H, De Vries, E G E, Sonke, G S & Gietema, J A 2020, ' High-Dose Chemotherapy with Hematopoietic Stem Cell Transplant in Patients with High-Risk Breast Cancer and 4 or More Involved Axillary Lymph Nodes : 20-Year Follow-up of a Phase 3 Randomized Clinical Trial ', JAMA Oncology, vol. 6, no. 4, pp. 528-534 . https://doi.org/10.1001/jamaoncol.2019.6276
JAMA oncology, 6(4), 528-534. American Medical Association
JAMA Oncology, 6(4), 528-534. AMER MEDICAL ASSOC
JAMA Oncol
Jama Oncology, 6, 528-534

Importance: Trials of adjuvant high-dose chemotherapy (HDCT) have failed to show a survival benefit in unselected patients with breast cancer, but long-term follow-up is lacking. Objective: To determine 20-year efficacy and safety outcomes of a large

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cc75b5fa1a0ce92730e37111e77ccec6
https://hdl.handle.net/2066/218567

End-stage cardiomyopathy because of hereditary hemochromatosis successfully treated with erythrocytapheresis in combination with left ventricular assist device support

Autor: Ger H. Koek, Elly M.C.J. Wajon, Wim M. Smit, Karin P.M. van Galen, Kateřina Martinakova, Aryan Vink, Corinne Klöpping, Nicolaas de Jonge, Cor van Bree, Eva Rombout-Sestrienkova

Publikováno v: Circulation-Heart Failure, 7(3), 541-543. LIPPINCOTT WILLIAMS & WILKINS

A 51-year-old man with a 2-year history of type II diabetes mellitus, erectile dysfunction, and 3-month history of fatigue was referred in March 2011 to the cardiology department of a local hospital because of 1 week of progressive dyspnea, orthopnea

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::889437114b995bf8dc751f82578970e3
https://doi.org/10.1161/CIRCHEARTFAILURE.114.001198

Health-related Internet use by patients with somatic diseases: Frequency of use and characteristics of users

Autor: Wim M. Smit, Sabine Siesling, Cornelia F. van Uden-Kraan, Constance H.C. Drossaert, Erik Taal, Erwin R. Seydel, Hein J. Bernelot Moens, Mart A F J van de Laar

Publikováno v: van Uden-Kraan, C F, Drossaert, C H C, Taal, E, Smit, W, Moens, H J B, Siesling, S, Seydel, E R & van de Laar, M A F J 2009, ' Health-related Internet use by patients with somatic diseases : Frequency of use and characteristics of users ', Informatics for health & social care, vol. 34, no. 1, pp. 18-29 . https://doi.org/10.1080/17538150902773272
Informatics for health & social care, 34(1), 18-29. Informa Healthcare
Informatics for health and social care, 34(1), 18-29. Informa Healthcare

The aim of this study was to explore the percentage of Dutch patients using the Internet to search for information about their illness. In addition, we studied patients' usage of health-related Internet applications, such as online patient support gr

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::017ab82e1741dd97e8d5d383b6aff9dc
https://doi.org/10.1080/17538150902773272

Pharmacogenetic Screening of CYP3A and ABCB1 in Relation to Population Pharmacokinetics of Docetaxel

Autor: Marcel Soesan, Alwin D. R. Huitema, Wim M. Smit, Tessa M. Bosch, Jos H. Beijnen, Els Witteveen, Robert S. Jansen, Rob L. H. Jansen, Jan H.M. Schellens, Valerie D. Doodeman, Carla M.L. van Herpen

Publikováno v: Clinical Cancer Research, 12, 19, pp. 5786-93
Clinical Cancer Research, 12, 5786-93

Purpose: Despite the extensive clinical experience with docetaxel, unpredictable interindividual variability in efficacy and toxicity remain important limitations associated with the use of this anticancer drug. Large interindividual pharmacokinetic

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c3c4581fa2c76c13cd125273cdd9113e
https://doi.org/10.1158/1078-0432.ccr-05-2649

α-Interferon with very-low-dose donor lymphocyte infusion for hematologic or cytogenetic relapse of chronic myeloid leukemia induces rapid and durable complete remissions and is associated with acceptable graft-versus-host disease

Autor: Ronald A. van Soest, Shama L. van Zelderen-Bhola, Willem E. Fibbe, J.H. Frederik Falkenburg, Roel Willemze, Wim M. Smit, C.W.J. Ingrid Starrenburg, Renee M.Y. Barge, Erik W.A. Marijt, Eduardus F. M. Posthuma, Inge O Baas

Publikováno v: Posthuma, E F M, Marijt, E W A F, Barge, R M Y, van Soest, R A, Baas, I O, Starrenburg, C W J I, van Zelderen-Bhola, S L, Fibbe, W E, Smit, W M, Willemze, R & Falkenburg, J H F 2004, ' α-Interferon with very-low-dose donor lymphocyte infusion for hematologic or cytogenetic relapse of chronic myeloid leukemia induces rapid and durable complete remissions and is associated with acceptable graft-versus-host disease ', Biology of Blood and Marrow Transplantation, vol. 10, no. 3, pp. 204-212 . https://doi.org/10.1016/j.bbmt.2003.11.003
Biology of Blood and Marrow Transplantation, 10(3), 204-212. Elsevier Inc.

Donor lymphocyte infusion (DLI) results in complete cytogenetic remission (CCR) of relapsed chronic-phase chronic myeloid leukemia (CML-CP) after allogeneic stem cell transplantation (SCT) in up to 80% of patients. The main complication of DLI is gra

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5690a1c9f9518e24222eb0c08f736a2a
http://www.scopus.com/inward/record.url?scp=10744226750&partnerID=8YFLogxK